Patent · US Active

Biomedical materials

US10967075B2 · kind B2 · utility

0Cited by
6References
21Claims
0Family size

Assignees

Inventors

Key dates

Filing dateJan 8, 2020
Grant dateApr 6, 2021
Priority date
Expiry dateJan 8, 2040

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61L2430/02
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A synthetic calcium phosphate-based biomedical material comprising gadolinium. The material may comprises a compound having the general chemical formula: Ca10−yGdy(PO4)6−x(SiO4)x(OH)2−x+y where 0<x<1.3 and 0<y<1.3.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.